07 June 2020
Visiongain has launched a new pharma report Dental Practice Management Software Market Report 2020-2030: Forecasts by Deployment Mode (Cloud-based, On-premise, Web-based), Application (Invoice/Billing Software, Insurance Management, Patient Communication Software, Payment Processing Software, Others), End User (Dental Clinics, Hospitals, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global dental practice management software market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020 on account of the growing healthcare IT sector coupled with favorable government initiatives in the oral healthcare industry.
The growing concern over oral hygiene and an increasing life expectancy has resulted in higher procedure volumes. An increasingly elderly population is also fueling the demand for dental implants. Growth in surgical procedural volumes increased patient awareness, and technological advances will, in turn, boost the growth of the dental implants market. Several companies are capitalizing on the growth opportunities offered by the dental implants market, both in developed nations such as the US and in emerging markets, by launching products with advanced features.
The advent and implementation of digital technology are driving the uniformity of the gathering, storing and using medical data, and applying pressure to clinical data-keeping. Dentistry lags somewhat behind medicine in terms of the quality of record keeping. Medical doctors must comply with stringent record keeping regulations, even on paper. They must be careful in recording data because the stakes are high. Lives can be lost. If data is improperly recorded and something goes wrong, there may not be an accurate record to refer to. Dental practitioners do not yet face this level of pressure to comply, although changes in this direction are just a matter of time.
The chances of dental problems are anticipated to rise with the rising aging population and this, in turn, is projected to demand dental practice management software across developed & emerging economies. However, the shortage of IT professionals is anticipated to restrain market growth over the forecast period.
North America dominated the global dental practice management software market owing to the rising elderly patient pool suffering from oral diseases. Also, the market will continue to be driven by the existence of the target population and growing investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing healthcare awareness and favorable government initiatives across markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the dental practice management software market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global dental practice management software market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the dental practice management software market.
The comprehensive market report features companies such as ACE Dental Software, Athenahealth, Inc., Carestream Dental, LLC, Compudent Systems Inc., Curve Dental, Inc., Datacon Dental Systems, Inc., DentiMax, LLC, Epic Systems Corporation, Gaargle Solutions Inc., Henry Schein, Inc., NextGen Healthcare, Inc., Patterson Companies, Inc., Practice Web, Inc., among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.
08 January 2021
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.
07 January 2021
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.
07 January 2021
The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.